Psoriasis and psoriatic arthritis have been associated with the underreporting and undertreatment of pain. To provide adequate care and management of pain in psoriatic disease, a multidisciplinary approach is required.
The prevalence of psoriasis in children and adolescents with type 1 diabetes mellitus is investigated.
Researchers evaluated the prevalence and severity of dermatologic inflammatory conditions in patients with IBD.
The approval was based on data from two phase 3 trials that evaluated the use of Cosentyx in patients 6 to 18 years of age with severe plaque psoriasis who were candidates for systemic therapy.
Individuals with co-occurrence of vitiligo and psoriasis have an increased risk for autoimmunity and family history of psoriasis.
A retrospective characterization of nonresponse to IL-17 inhibitors in patients with psoriasis was conducted.
Anne-Claire Fougerousse, MD, elaborates on a recent study regarding psoriasis, SBTs, and COVID-19.
Greater skin clearance among psoriasis patients is associated with greater improvements in quality of life.
Psoriasis may be another risk factor for infectious complications in patients receiving dialysis, according to investigators.
Researchers assessed sex differences in disease activity parameters and health-related quality of life in psoriatic arthritis.
